Featured Partners

Novartis Sets Sights on Return to Growth in 2018

(Reuters) — Novartis (No. 2 on the 2016 DiversityInc Top 50 Companies list) reported better-than-expected first-quarter profits on April 25 with Chief Executive Joe Jimenez saying he remained confident the Swiss drugmaker would return to growth in 2018 as spending to promote new drugs pays off. First-quarter core net income…